Profile
Bruce R.
York worked as a Finance Director, Controller, Manager-Tax & Assets at Physio Control International Corp.
from 1987 to 1998.
He then worked as a Finance Director at CTI BioPharma Corp.
from 1998 to 1999.
From 1999 to 2004, he served as the Chief Financial Officer, Secretary & VP at Cellular Technical Services Co., Inc. Later, he worked as the Chief Accounting Officer & VP-Finance at MDRNA, Inc. from 2009 to 2010.
Mr. York completed his undergraduate degree and MBA from Dartmouth College.
Former positions of Bruce R. York
Companies | Position | End |
---|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Director of Finance/CFO | 2009-09-14 |
Cellular Technical Services Co., Inc.
Cellular Technical Services Co., Inc. Financial ConglomeratesFinance The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes. | Director of Finance/CFO | 2003-12-31 |
CTI BIOPHARMA CORP. | Director of Finance/CFO | 1998-12-31 |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Physio-Control International Corp. was previously designed, manufactured and sold integrated line of noninvasive emergency cardiac defibrillators, vital sign assessment devices, disposable electrodes and related data management software. It was headquartered in Redmond, WA. | Director of Finance/CFO | 1997-12-31 |
Training of Bruce R. York
Dartmouth College | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Cellular Technical Services Co., Inc.
Cellular Technical Services Co., Inc. Financial ConglomeratesFinance The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes. | Finance |
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Physio-Control International Corp. was previously designed, manufactured and sold integrated line of noninvasive emergency cardiac defibrillators, vital sign assessment devices, disposable electrodes and related data management software. It was headquartered in Redmond, WA. | Health Technology |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
- Stock Market
- Insiders
- Bruce R. York